Australian Clinical Labs Ltd (AU:ACL) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Australian Clinical Labs Ltd saw significant changes in its substantial holdings as Mitsubishi UFJ Financial Group, Inc. ceased being a substantial holder. The changes involved numerous transactions, primarily purchases of securities controlled by Morgan Stanley, significantly altering the voting interests in the company. This development marks a shift in the investment landscape for Australian Clinical Labs, potentially impacting its market position.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.